We recently published a list of S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Sentiment. In this article, we are ...

We recently published a list of 10 Best Retirement Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best ...

Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in ...

For investors seeking a balance of risk management and income, a mix of low-volatility, high-dividend stocks can be a smart ...

Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...

The Japanese Ministry of Health, Labor and Welfare (MHLW) in Japan has approved Sarclisa (isatuximab), in combination with ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price objective cut by research analysts at The Goldman Sachs Group from $43.00 to $38.00 in a report released on Monday,Benzinga ...

Nasdaq 100, S&P 500, Dow Jones Industrial Average, Coca-Cola Co. Read MarketBeat.com (Ryan Hasson)'s latest article on Investing.com ...

"The demand environment remains consistent with our view of a gradual recovery in 2025," said CEO Satish Dhanasekaran.